The approach taken here begins with a broad screen of the market, narrowing the field to stocks with a solid dividend profile that also demonstrate financial stability and consistent profitability. The thinking is that a high dividend yield alone is not enough; the company must be healthy enough to sustain those payments and profitable enough to potentially grow them. Gentex Corp (NASDAQ:GNTX) emerges as a candidate that ticks all these boxes, making it a name worth investigating for income-focused investors.
This screen specifically filters for stocks with a ChartMill Dividend Rating of 7 or higher, ensuring the dividend is not only attractive but also backed by a strong track record and sound financial footing. Additionally, the screen requires a ChartMill Health Rating of at least 5 and a Profitability Rating of at least 5, which serves as a gatekeeper against companies where the dividend might be at risk due to underlying financial weakness. Gentex scores a 7 on the Dividend Rating, an 8 on Health, and an 8 on Profitability, indicating a strong profile across all three crucial dimensions.
Dividend Profile
The core of the strategy is the dividend, and Gentex presents an attractive case here. The current yearly dividend yield stands at 1.96%, which, while not the highest in the market, is significantly better than the industry average of 0.68%, placing it in the top 14% of its peers. This is a yield that offers a tangible return without the red flags often associated with unsustainable, ultra-high payouts.
Key strengths in the dividend assessment include:
- Reliable History: Gentex has paid a dividend for at least 10 consecutive years and has never decreased its payout over that period. This long, unbroken track record provides a strong foundation of reliability.
- Sustainable Payout: With a payout ratio of just 27.57%, the company retains the vast majority of its earnings. This means there is ample room to maintain the current dividend even if earnings face temporary pressure, and it also provides capital for reinvestment in the business.
- Growing Dividend: While the annual dividend growth rate of 0.39% is modest, it is important to note that earnings are growing at a faster pace. This indicates that the dividend growth is considered sustainable, a key factor for long-term investors.
The low payout ratio is directly tied to the earlier method's insistence on health and profitability. It's the buffer that protects the dividend when market conditions get tough, confirming that the yield is a genuine return on investment rather than a potential trap.
Profitability and Health
The screen's filters for profitability and health are not secondary considerations; they are the pillars that support the dividend. A company that cannot generate consistent profits will eventually be forced to cut its payments. Gentex scores well here, reinforcing the durability of its dividend.
- Profitability: The company has a Profitability Rating of 8 out of 10. This is driven by strong returns on assets (12.76%), equity (15.28%), and invested capital (16.64%), all of which are among the best in its industry. This consistent profitability provides the cash flow necessary to fund both the dividend and future growth.
- Financial Health: With a Health Rating of 8, Gentex is on very solid ground. Its Altman-Z score of 8.59 indicates a virtually zero risk of bankruptcy, and its debt-to-equity ratio is essentially zero. This clean balance sheet means there are no looming debt obligations that could force management to divert cash away from shareholder returns.
In essence, the company is not just paying a dividend; it is generating the profits and maintaining the financial strength to do so indefinitely. This confirms the initial screening criteria's value: strong health and profitability are the necessary prerequisites for a truly reliable dividend stock.
Valuation and Growth
A dividend strategy does not operate in a vacuum. The price paid for the stock directly impacts the yield, and future growth determines whether that yield will increase over time. Gentex offers a reasonable valuation that adds another layer of appeal.
The stock trades at a Price/Earnings (P/E) ratio of 12.76, which is lower than 72% of its industry peers and roughly half the average P/E of the S&P 500. This suggests the stock is not overpriced, providing a margin of safety. Furthermore, earnings are expected to grow by 12.76% in the coming years, which should support future dividend increases.
A detailed breakdown of the company's financial health, profitability, and dividend prospects is available in the full fundamental analysis report on ChartMill.
Analyst Views
The overall rating of 7 out of 10 reflects a company that is solid across the board without being a top performer in any single area. The 8 for profitability and 8 for health are standout scores, while the growth score of 4 is the weaker link, primarily due to a recent decline in revenue. However, the forward-looking metrics are more optimistic, with expected EPS growth of 14.75%. This suggests the short-term dip may be a temporary issue, and the long-term trajectory remains positive. The combination of a reliable dividend, strong balance sheet, and reasonable valuation makes it a stock that can be held with confidence through various market cycles.
Looking for More Opportunities?
This analysis of Gentex is just one example of what can be found using a systematic screening approach. The stock was identified by a screen designed to find the best dividend stocks by prioritizing a high dividend rating alongside solid health and profitability metrics.
To explore a wider selection of stocks that meet these same criteria, you can run the complete screen for yourself. This will generate a dynamic list of candidates, allowing you to compare and evaluate other potential investments that fit this disciplined, income-focused strategy.
View the full list of Best Dividend Stocks here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research or consult with a financial advisor before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Gentex Corp (NASDAQ:GNTX) Delivers Strong Dividend, Health, and Profitability Metrics
The approach taken here begins with a broad screen of the market, narrowing the field to stocks with a solid dividend profile that also demonstrate financial stability and consistent profitability. The thinking is that a high dividend yield alone is not enough; the company must be healthy enough to sustain those payments and profitable enough to potentially grow them. Gentex Corp (NASDAQ:GNTX) emerges as a candidate that ticks all these boxes, making it a name worth investigating for income-focused investors.
This screen specifically filters for stocks with a ChartMill Dividend Rating of 7 or higher, ensuring the dividend is not only attractive but also backed by a strong track record and sound financial footing. Additionally, the screen requires a ChartMill Health Rating of at least 5 and a Profitability Rating of at least 5, which serves as a gatekeeper against companies where the dividend might be at risk due to underlying financial weakness. Gentex scores a 7 on the Dividend Rating, an 8 on Health, and an 8 on Profitability, indicating a strong profile across all three crucial dimensions.
Dividend Profile
The core of the strategy is the dividend, and Gentex presents an attractive case here. The current yearly dividend yield stands at 1.96%, which, while not the highest in the market, is significantly better than the industry average of 0.68%, placing it in the top 14% of its peers. This is a yield that offers a tangible return without the red flags often associated with unsustainable, ultra-high payouts.
Key strengths in the dividend assessment include:
The low payout ratio is directly tied to the earlier method's insistence on health and profitability. It's the buffer that protects the dividend when market conditions get tough, confirming that the yield is a genuine return on investment rather than a potential trap.
Profitability and Health
The screen's filters for profitability and health are not secondary considerations; they are the pillars that support the dividend. A company that cannot generate consistent profits will eventually be forced to cut its payments. Gentex scores well here, reinforcing the durability of its dividend.
In essence, the company is not just paying a dividend; it is generating the profits and maintaining the financial strength to do so indefinitely. This confirms the initial screening criteria's value: strong health and profitability are the necessary prerequisites for a truly reliable dividend stock.
Valuation and Growth
A dividend strategy does not operate in a vacuum. The price paid for the stock directly impacts the yield, and future growth determines whether that yield will increase over time. Gentex offers a reasonable valuation that adds another layer of appeal.
The stock trades at a Price/Earnings (P/E) ratio of 12.76, which is lower than 72% of its industry peers and roughly half the average P/E of the S&P 500. This suggests the stock is not overpriced, providing a margin of safety. Furthermore, earnings are expected to grow by 12.76% in the coming years, which should support future dividend increases.
A detailed breakdown of the company's financial health, profitability, and dividend prospects is available in the full fundamental analysis report on ChartMill.
Analyst Views
The overall rating of 7 out of 10 reflects a company that is solid across the board without being a top performer in any single area. The 8 for profitability and 8 for health are standout scores, while the growth score of 4 is the weaker link, primarily due to a recent decline in revenue. However, the forward-looking metrics are more optimistic, with expected EPS growth of 14.75%. This suggests the short-term dip may be a temporary issue, and the long-term trajectory remains positive. The combination of a reliable dividend, strong balance sheet, and reasonable valuation makes it a stock that can be held with confidence through various market cycles.
Looking for More Opportunities?
This analysis of Gentex is just one example of what can be found using a systematic screening approach. The stock was identified by a screen designed to find the best dividend stocks by prioritizing a high dividend rating alongside solid health and profitability metrics.
To explore a wider selection of stocks that meet these same criteria, you can run the complete screen for yourself. This will generate a dynamic list of candidates, allowing you to compare and evaluate other potential investments that fit this disciplined, income-focused strategy.
View the full list of Best Dividend Stocks here.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research or consult with a financial advisor before making investment decisions.
Read full article here »